Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Bandhan BSE Healthcare Index Fund (G) Direct |
[Equity: Index] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
-0.27 |
Equity |
100.11 |
Trep |
0.16 |
|
|
Concentration Analysis |
Top 5 Holdings |
37.87% |
Top 10 Holdings |
56.15% |
Top 25 Holdings |
78.55% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
74.05 |
Healthcare |
26.06 |
Cash |
-0.11 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
5.88 |
PE Ratio |
42.05 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
12.79 |
Cipla Limited |
6.83 |
Max Healthcare Institute Limited |
6.48 |
DIVI LABORATORIES LTD |
5.92 |
Dr Reddys Laboratories Limited |
5.85 |
Apollo Hospitals Enterprise Limited |
5.82 |
Fortis Health Care Ltd |
3.61 |
Lupin Limited |
3.48 |
Torrent Pharmaceuticals Limited |
2.84 |
Laurus Labs Limited |
2.53 |
Glenmark Pharmaceuticals Limited |
2.19 |
Aurobindo Pharma Limited |
2.18 |
Alkem Laboratories Limited |
2.17 |
MANKIND PHARMA LIMITED |
2.09 |
Zydus Lifesciences Limited |
1.88 |
Biocon Limited |
1.52 |
IPCA Laboratories Limited |
1.46 |
Krishna Inst of Medical Sciences Ltd. |
1.35 |
Cohance Lifesciences Limited |
1.28 |
Abbott India Limited |
1.22 |
Gland Pharma Limited |
1.12 |
J B Chemicals and Pharma Ltd |
1.06 |
Aster DM Healthcare Limited |
1.03 |
Dr Lal Path Labs Ltd |
0.95 |
Wockhardt Limited |
0.90 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|